Suppr超能文献

药物处置研究的目的和时间安排,附录IV。保泰松制剂:体外溶出度和体内性能。

The objective and timing of drug disposition studies, appendix IV. Phenylbutazone formulations: in vitro dissolution and in vivo performance.

作者信息

Leeson L J, Shinal E C, Lukas G, Zak S B, Weiner M

出版信息

Drug Metab Rev. 1975;4(2):277-84. doi: 10.3109/03602537508993761.

Abstract

Human plasma level studies were conducted on various phenylbutazone formulations. The resultant data indicated that the nature of the formulation had a marked influence on the rate of phenylbutazone absorption. An in vitro dissolution rate apparatus was employed in an attempt to predict potential absorption of phenylbutazone from a given formulation. Based upon the in vitro-in vivo correlation, a new phenylbutazone tablet product was developed which produced a complete and more rapid absorption of the drug.

摘要

对多种保泰松制剂进行了人体血浆水平研究。所得数据表明,制剂的性质对保泰松的吸收速率有显著影响。采用体外溶出速率装置,试图预测保泰松从给定制剂中的潜在吸收情况。基于体外-体内相关性,开发了一种新的保泰松片剂产品,该产品能使药物实现完全且更快的吸收。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验